Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Weitz

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Thrombosis Research|March 1, 2005
Heparin compromises streptokinase-induced arterial patency in rabbitsM Vlasin, J Rak, J I Weitz, et al.
The Journal of Experimental Medicine|December 1, 1987
Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinasesJ I Weitz, A J Huang, S L Landman, et al.
The Journal of Biological Chemistry|September 17, 1999
Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor IIP C Liaw, R C Austin, J C Fredenburgh, et al.
Circulation|February 9, 1999
Vasoflux, a new anticoagulant with a novel mechanism of actionJ I Weitz, E Young, M Johnston, et al.
Thrombosis and Haemostasis|April 20, 2001
Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasminA Y Lee, J C Fredenburgh, R J Stewart, et al.
Blood|February 9, 1999
A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in ratsS G Shaughnessy, J Hirsh, M Bhandari, et al.
Thrombosis and Haemostasis|October 6, 1998
The effects of standard and low molecular weight heparin on bone nodule formation in vitroM Bhandari, J Hirsh, J I Weitz, et al.
Thrombosis and Haemostasis|August 20, 1986
Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogenC Y Liu, J H Sobel, J I Weitz, et al.
The Journal of Biological Chemistry|April 11, 2001
Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparinP C Liaw, D L Becker, A R Stafford, et al.
Journal of Thrombosis and Haemostasis : JTH|June 19, 2015
Global public awareness of venous thromboembolismA M Wendelboe, M McCumber, E M Hylek, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Thrombosis Research|March 1, 2005
Heparin compromises streptokinase-induced arterial patency in rabbitsM Vlasin, J Rak, J I Weitz, et al.
The Journal of Experimental Medicine|December 1, 1987
Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinasesJ I Weitz, A J Huang, S L Landman, et al.
The Journal of Biological Chemistry|September 17, 1999
Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor IIP C Liaw, R C Austin, J C Fredenburgh, et al.
Circulation|February 9, 1999
Vasoflux, a new anticoagulant with a novel mechanism of actionJ I Weitz, E Young, M Johnston, et al.
Thrombosis and Haemostasis|April 20, 2001
Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasminA Y Lee, J C Fredenburgh, R J Stewart, et al.
Blood|February 9, 1999
A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in ratsS G Shaughnessy, J Hirsh, M Bhandari, et al.
Thrombosis and Haemostasis|October 6, 1998
The effects of standard and low molecular weight heparin on bone nodule formation in vitroM Bhandari, J Hirsh, J I Weitz, et al.
Thrombosis and Haemostasis|August 20, 1986
Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogenC Y Liu, J H Sobel, J I Weitz, et al.
The Journal of Biological Chemistry|April 11, 2001
Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparinP C Liaw, D L Becker, A R Stafford, et al.
Journal of Thrombosis and Haemostasis : JTH|June 19, 2015
Global public awareness of venous thromboembolismA M Wendelboe, M McCumber, E M Hylek, et al.
Pageof 14